Skip to main content

We are aiming for an incremental return to campus in accordance with guidelines provided by NSW Health and the Australian Government. Until this time, learning activities and assessments will be planned and scheduled for online delivery where possible, and unit-specific details about face-to-face teaching will be provided on Canvas as the opportunities for face-to-face learning become clear.

We are currently working to resolve an issue where some unit outline links are unavailable. If the link to your unit outline does not appear below, please use the link in your Canvas site. If no link is available on your Canvas site, please contact your unit coordinator.

Unit of study_

BMET1961: Biomedical Engineering 1B

This biomedical engineering core junior unit of study provides an introduction to the relatively recent, and rapidly growing, biotechnology industry, with a focus on the current key commercial applications. In the 1990s, the word 'biotech' entered our lexicon as a synonym for overnight investment wealth. The biotechnology acronym GM (genetically modified) also entered our lexicon in the 1990s. Biotechnology can be broadly defined as the commercial exploitation of biological processes for industrial and other purposes. A significant focus for commercial activities has been GM technology: GM microorganisms, plants, animals, and even humans (gene therapy). The 'biotech industry' arose rapidly in the late 20th century, and is now one of the largest industries in the world, and is one of the cornerstones of the global biomedical industry which comprises three main sectors: Medical Devices, Pharmaceuticals, and Biotechnology. Significant global commercial biotechnology activity concerns the manufacture of therapeutic compounds from GM microorganisms using bioreactors, for example insulin. Another significant sector is agricultural: 'agri-biotech' which concerns GM higher lifeforms (plants and animals) primarily for the food industry, and also other industries such as the energy industry (biofuels). The third sector concerns therapeutic GM of humans, known as 'gene-therapy'. Some other important biotechnologies will also be explored including monoclonal antibodies, genome sequencing and personalised medicine, and RNA-interference technology (RNAi).

Code BMET1961
Academic unit Biomedical Engineering
Credit points 6
Prerequisites:
? 
None
Corequisites:
? 
None
Prohibitions:
? 
AMME1961

At the completion of this unit, you should be able to:

  • LO1. demonstrate scientific oral, and written communication skills, ethics in scientific research, and application of engineering technology in biomedical applications
  • LO2. demonstrate a general understanding of the cell biology, the functions of their inbuilt cellular components, integrating engineering principles to life sciences and their applications in biomedical engineering.
  • LO3. demonstrate a practical understanding of gene therapy and personalised medicine, medical imaging techniques and their applications in the field of biomedical engineering
  • LO4. Demonstrate a general understanding of the bioreactors, process analysis and automation, and computation. Demonstrate a fundamental understanding of Additive manufacturing nanotechnology concepts and their applications in biomedical engineering.
  • LO5. Demonstrate procedure for working safely, correctly and effectively in a molecular biology laboratory. Learn and demonstrate a range of practical techniques in molecular biology. Demonstrate a collaborative experimental work, effective data acquisition, analysis, data recording and experimental report writing

Unit outlines

Unit outlines will be available 2 weeks before the first day of teaching for 1000-level and 5000-level units, or one week before the first day of teaching for all other units.

There are no unit outlines available online for previous years.